GSK
GSK
863 hedge funds and large institutions have $14.2B invested in GSK in 2025 Q1 according to their latest regulatory filings, with 91 funds opening new positions, 328 increasing their positions, 280 reducing their positions, and 68 closing their positions.
91% more capital inflows, than outflows
Capital inflows: $1.92B | Capital outflows: $1B
66% more call options, than puts
Call options by funds: $243M | Put options by funds: $146M
34% more first-time investments, than exits
New positions opened: 91 | Existing positions closed: 68
17% more repeat investments, than reductions
Existing positions increased: 328 | Existing positions reduced: 280
17% more funds holding in top 10
Funds holding in top 10: 12 → 14 (+2)
1.26% more ownership
Funds ownership: 16.75% → 18.02% (+1.3%)
1% more funds holding
Funds holding: 853 → 863 (+10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$410M |
| 2 |
Dodge & Cox
San Francisco,
California
|
+$374M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$267M |
| 4 |
Holocene Advisors
New York
|
+$175M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$97.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JTC Employer Solutions Trustee
St Helier,
Jersey
|
-$184M |
| 2 |
Camber Capital Management
Boston,
Massachusetts
|
-$91.5M |
| 3 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
-$73.7M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$73.2M |
| 5 |
Armistice Capital
New York
|
-$73.2M |
GSK Hedge Fund Activity: Q1 2025 in Review
863 of the 7,489 institutional investors tracked by Wall St. Rank reported a position in GSK (GSK) for Q1 2025, worth a combined $14.2B — up 23% from $11.6B a quarter earlier.
Buyers outnumbered sellers: 91 funds opened new GSK positions and 68 closed out — a net gain of 23 holders — while 328 added to existing stakes and 280 trimmed.
The largest buyer was Fisher Asset Management, adding an estimated $410M. The largest seller was JTC Employer Solutions Trustee, cutting an estimated $184M.
- 863 institutional investors held GSK (GSK) as of Q1 2025, up from 853 in Q4 2024.
- Funds reported $14.2B of GSK stock for Q1 2025, up 23% quarter-over-quarter.
- 91 funds opened new GSK positions in Q1 2025 and 68 closed out, a net change of +23 holders.
- The largest GSK buyer in Q1 2025 was Fisher Asset Management, an estimated $410M added.
- The largest GSK seller in Q1 2025 was JTC Employer Solutions Trustee, an estimated $184M sold.
Based on aggregated 13F filings for Q1 2025.